Jenburkt Pharmaceuticals

1,099.40
0.00
(0.00%)
Market Cap
485.20
Eps
58.86
PE Ratio (TTM)
15.45
Dividend Yield
1.39
Industry
Healthcare
52 Week High
1,375.00
52 Week low
660.05
PB Ratio
3.08
Debt to Equity
0.01
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
3.31 %
Net Income Growth
5.69 %
Cash Flow Change
-52.38 %
ROE
-10.89 %
ROCE
-9.60 %
EBITDA Margin (Avg.)
3.00 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
87
96
106
118
126
123
114
129
142
147
156
Expenses
70
77
84
91
98
99
90
97
106
109
110
EBITDA
17
19
23
27
28
24
24
32
36
38
45
Operating Profit %
18 %
18 %
19 %
21 %
20 %
17 %
18 %
22 %
22 %
23 %
26 %
Depreciation
3
2
2
2
1
2
2
2
2
2
3
Interest
0
0
0
0
0
1
1
0
0
0
0
Profit Before Tax
14
17
21
25
27
21
22
30
33
35
43
Tax
5
6
7
8
7
6
5
8
8
9
11
Net Profit
10
11
14
17
20
15
17
22
25
26
31
EPS in ₹
20.75
23.18
29.05
37.50
43.14
32.40
35.96
48.58
53.90
58.86
71.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
61
58
76
78
103
104
121
143
142
165
Fixed Assets
12
12
11
10
10
12
11
11
10
10
Current Assets
49
45
64
66
90
90
80
76
81
110
Capital Work in Progress
0
0
0
0
1
0
0
0
1
1
Investments
0
0
2
5
5
4
7
8
11
17
Other Assets
49
46
64
63
87
88
104
123
119
137
Total Liabilities
61
58
76
78
103
104
121
143
142
165
Current Liabilities
24
14
18
13
23
20
18
21
16
16
Non Current Liabilities
4
4
4
3
3
5
5
4
4
4
Total Equity
33
40
54
61
78
80
99
117
122
145
Reserve & Surplus
29
36
50
57
73
75
94
113
118
141
Share Capital
5
5
5
5
5
5
5
5
4
4

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
11
2
1
-1
0
1
0
3
-1
1
Investing Activities
1
-0
-10
1
-11
-3
-19
-1
3
-1
Operating Activities
9
8
10
16
13
15
20
9
17
8
Financing Activities
1
-5
1
-18
-2
-11
-1
-6
-21
-7

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.97 %
47.56 %
47.56 %
47.42 %
47.39 %
47.23 %
46.71 %
46.71 %
46.69 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.12 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
44.30 %
42.77 %
42.81 %
41.55 %
41.28 %
41.33 %
40.77 %
41.24 %
40.37 %
41.12 %
41.48 %
41.99 %
42.65 %
43.39 %
43.56 %
43.43 %
No of Share Holders
6,825
6,873
6,626
6,116
6,053
6,016
5,896
5,784
5,611
5,741
5,872
6,021
6,316
6,419
6,628
6,901

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,754.25 4,20,903.34 35.94 49,887.20 12.06 9,648 13.77 47.04
6,122.80 1,62,541.10 78.25 8,184.00 0.89 1,600 64.53 59.36
1,453.95 1,17,423.04 23.45 26,520.70 14.17 4,155 47.38 49.10
3,110.80 1,05,283.61 56.43 10,785.70 11.59 1,656 13.54 34.52
2,525.55 1,04,195.83 51.56 10,615.60 19.57 1,942 -16.38 46.81
1,228.50 1,02,507.38 18.95 28,905.40 12.36 5,578 1.69 38.90
2,162.50 98,652.72 36.66 20,141.50 19.94 1,936 73.53 48.22
977.70 98,379.50 22.90 19,831.50 13.82 3,831 14.57 51.14
1,184.65 68,804.66 18.82 29,559.20 17.55 3,169 8.66 45.72
5,190.00 62,054.24 28.08 12,978.40 9.84 1,812 14.16 42.91

Corporate Action

Technical Indicators

RSI(14)
Neutral
37.49
ATR(14)
Less Volatile
58.21
STOCH(9,6)
Oversold
14.78
STOCH RSI(14)
Oversold
1.82
MACD(12,26)
Bearish
-11.86
ADX(14)
Weak Trend
24.33
UO(9)
Bearish
38.84
ROC(12)
Downtrend And Accelerating
-11.69
WillR(14)
Oversold
-94.41